Sort
46,585 grants matching “heart failure”
Portable electrical nitric oxide generator for treatment of pulmonary hypertension accompanying interstitial lung disease
$998,712Greg Hall · Third Pole, Inc. · R44 · FY2021 · TR
Treatment of Preserved Systolic Function with an Aldosterone Antagonist
$998,642Rebecca Li · New England Research Institutes, Inc. · N01 · FY2014 · HL
Mitigation of Acute Kidney Injury (AKI) using the polymer prodrug, APP-103TM
$998,624Brandy Lynn Houser · Celdara Medical, Llc · R44 · FY2020 · DK
Miniature MagLev VAD for Neonates and Pediatrics
$998,327Kurt A Dasse · Thoratec, Llc · R44 · FY2010 · HL
Chronic Kidney Disease in Children (CKiD III)
$998,262Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2016 · DK
UC BRAID Center for Accelerated Innovation
$998,230Michael J Palazzolo · University Of California Los Angeles · U54 · FY2019 · HL
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study
$998,176James S Floyd · University Of Washington · R01 · FY2020 · HL
Polygenic risk scores and health disparities: the role of blood cells immune response and evolutionary adaptation
$998,059Yun Li · Univ Of North Carolina Chapel Hill · U01 · FY2023 · HG
Mitochondrial Integrated Stress Response in Neurological Diseases
$998,006Giovanni Manfredi · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · NS
An automated platform for direct-from-specimen identification of pathogens common in endocarditis
$998,005Alon Singer · Helixbind, Inc. · R44 · FY2020 · AI
BiVACOR - A Physiological, Durable and Blood-Friendly Total Artificial Heart
$997,998Daniel Timms · Bivacor, Inc. · R44 · FY2022 · HL
Transcatheter Device for Congestive Heart Failure Treatment Through Left Atrial Decompression
$997,944Thomas Diffley Pate · Alleviant Medical, Inc. · R44 · FY2024 · HL
Myocardial Ischemia and Transfusion (MINT) - CCC
$997,942Jeffrey Lee Carson · Rutgers Biomedical And Health Sciences · U01 · FY2022 · HL
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
$997,867Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · AI
Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection
$997,867Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2024 · AI
Development of a Total Artificial Lung
$997,603Robert H. Bartlett · University Of Michigan At Ann Arbor · R01 · FY2011 · HL
APPLIED GENOMICS IN CARDIOPULMONARY DISEASE
$997,577Johns Hopkins University · U01 · FY2002 · HL
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
$996,733Norman E Breslow · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
REACH: Research Empowerment for Adult Congenital Hearts
$996,091David J. Sahn · Oregon Health & Science University · RC4 · FY2010 · HL
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
$995,592Jonathan A Winger · Omniox, Inc. · R44 · FY2024 · HD
Diabetes and Heart Disease Risk in Blacks
$995,454Anne Sumner · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK
Digital Microfluidics - Minimizing Blood Volume for Pediatric Coagulation Screening
$995,191Vamsee K Pamula · Baebies, Inc. · R44 · FY2020 · HL
MAGNETICALLY SUSPENDED ROTOR BLOOD PUMP
$995,156Utah Artificial Heart Institute · R01 · FY2000 · HL
Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with Noonan Syndrome with Multiple Lentigines (NSML)
$995,100Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Use of Rapamycin for the Treatment of Hypertrophic Cardiomyopathy in Patients with Noonan Syndrome with Multiple Lentigines (NSML)
$995,100Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR